Condition (MeSH)
Ethmoid Sinusitis
ClinicalTrials.gov lists 3 trials for Ethmoid Sinusitis or a narrower condition beneath it. Sinopsys Surgical has the most among industry and government lead sponsors, with 2.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
3 of the 3 trials are tagged with Ethmoid Sinusitis itself; the rest are tagged with a narrower condition beneath it.
When did Ethmoid Sinusitis trials start? (3)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 4
- Not applicable
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2016 | 1 |
| 2015 | 1 |
| 2007 | 1 |
No forecast is made for this condition: it averages 0.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 3 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Ethmoid Sinusitis trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
| Not applicable | 1 |
How many Ethmoid Sinusitis trials are recruiting? (1)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Completed | 3 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Ethmoid Sinusitis trials? (2)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Sinopsys Surgical | 2 |
| Carbylan Therapeutics, Inc. | 1 |
Which publications cover Ethmoid Sinusitis? (7)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Steroid-independent upregulation of matrix metalloproteinase 9 in chronic rhinosinusitis patients with radiographic evidence of osteitis. | International forum of allergy & rhinology | 2013 | Yes |
| Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent. | International forum of allergy & rhinology | 2011 | Yes |
| Prognostic factors, outcomes and staging in ethmoid sinus surgery. | The Laryngoscope | 1992 | Yes |
| Chronic sinusitis refractory to standard management in patients with humoral immunodeficiencies. | Clinical and experimental immunology | 1997 | No |
| Anesthesia for stereotactic radiosurgery in children. | Journal of neurosurgical anesthesiology | 1995 | No |
Showing 5 of 7 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.
Not computed for conditions with fewer than 10 trials: drugs tested.